Intuitive Surgical (ISRG) Cash & Equivalents (2009 - 2026)

Intuitive Surgical's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $2.8 billion for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 19.91% year-over-year to $2.8 billion; the TTM figure through Jun 2026 stood at $2.8 billion (down 19.91% YoY), while the FY2025 annual figure was $3.4 billion, up 63.3% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $2.8 billion, up from $2.0 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $3.6 billion in Q3 2023, with the low at $1.1 billion in Q1 2022.
• The 5-year median for Cash & Equivalents is $2.7 billion (2025), against an average of $2.5 billion.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 134.2% in 2023, then plunged 32.08% in 2024.
• Intuitive Surgical's Cash & Equivalents stood at $1.6 billion in 2022, then surged by 75.19% to $2.8 billion in 2023, then fell by 25.55% to $2.1 billion in 2024, then soared by 63.3% to $3.4 billion in 2025, then dropped by 18.04% to $2.8 billion in 2026.
• Business Quant data shows ISRG's Cash & Equivalents at $2.8 billion in Q2 2026, $2.0 billion in Q1 2026, and $3.4 billion in Q4 2025.